Russia - Healthcare, Regulatory and Reimbursement Landscape

Report
143 Pages
December 2021
Region: Russia
GlobalData
ID: 4142710

The publisher, the industry analysis specialist, has released its latest report “Russia - Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Russia. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher’s team of industry experts.

The Russian pharmaceutical market is one of the most significant markets in the Central and Eastern European (CEE) region. The Russian Government launched a new strategy, “Pharma 2030,” to encourage the production of active ingredients and innovative biological and pathogenetic drugs, improve the existing drug insurance system, and improve the local pharmaceutical market. The growth in the Russian healthcare market is attributed to reforms in regulatory guidelines, government initiatives to develop the domestic pharmaceutical market, and the growing elderly population. However, the limited access to healthcare facilities, price cuts, high out-of-pocket (OOP) payments, and low R&D expenditure may hinder this growth. The Russian pharmaceutical market, in the terms of US dollars, increased from $22.9B in 2015 to $29.0B in 2020 and is estimated to increase at a CAGR of 4.81% to $38.4B in 2026. The medical devices market in Russia was valued at $10.5B in 2016, which increased to $11.4B in 2020 at a CAGR of 2.1%. The market is expected to grow at a CAGR of 0.37% from $11.3B in 2021 to $11.5B in 2026.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
Profiles and SWOT analyses of the major players in the pharmaceutical market: GSK, Sanofi, Pfizer, Novartis, and Pharmstandard.
Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Zimmer, and Medtronic.
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
An overview of the opportunities for and challenges to growth in the Russian healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Russian healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Russian healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights: Facts about the Russia Healthcare Market
2.3 Key Highlights: Healthcare Start-ups in Russia
2.4 Key Events: Healthcare Industry, Russia, 2015-2021
2.5 Key Events: Russia Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021
2.7 Key Events: Top Completed Deals by Value, 2020-2021
2.8 Country Profile, Russia, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Russia
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Russia
3.7 COVID-19 Epidemiology, Russia
3.8 COVID-19 Impact and Developments, Russia
3.9 COVID-19 Impact and Developments in the Healthcare Market, Russia
3.10 COVID-19 Clinical Trials Landscape, Russia
3.11 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Russia, 2020-2021
6.2 Deal Analysis: Medical Device Market, Russia, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Russia
7.2 HealthTech Deals Landscape, Russia
7.3 Key HealthTech Deals, Russia
7.4 Adoption of Technology in Healthcare, Russia
7.5 Digital Health Regulations, Russia
7.6 HealthTech Landscape - Benefits and Risks, Russia

8. Market Access

8.1 Overview of Healthcare System, Russia
8.2 Reimbursement Process, Russia
8.3 Overview of Insurance Providers, Russia
8.4 Out-of-Pocket Spending and Consumer Price Index, Russia
8.5 Pricing Policies, Russia
8.6 Regulatory Landscape, Russia
8.6.1 Overview of Regulatory Agencies, Russia
8.6.2 Marketing Authorization for Pharmaceutical Products, Russia
8.6.3 Marketing Authorization for Medical Devices, Russia
8.6.4 Regulatory Reforms, Russia
8.6.5 Pharmaceutical Exports and Imports, Russia
8.6.6 Intellectual Property Rights, Patent, Russia
8.6.7 Clinical Trial Regulations, Russia
8.6.8 Pharmaceutical Clinical Trials Landscape, Russia
8.6.9 Medical Devices Clinical Trials Landscape, Russia
8.6.10 Pharmaceutical and Medical Device Advertising Regulations, Russia
8.6.11 Labeling and Packaging Regulations, Russia

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Russia
9.2 Healthcare Facilities, Russia
9.3 Healthcare Parameters, Russia
9.4 Life Expectancy and Immunization Rate, Russia
9.5 Environmental Health, Russia
9.6 Healthcare Personnel, Russia
9.7 Disease Burden, Russia
9.8 Healthcare Expenditure, Russia

10 Trade Associations, Russia11 Trade Fairs, Russia12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About The Publisher
13.4 Contact The Publisher
13.5 Disclaimer

List of Tables

Table 1: Major Pharmaceutical Distributors, Russia, Q1- Q3 2021
Table 2: Sales Structure of “Temporary Recommendations for Use” (RTU drugs) by ATC groups, Russia, 2018
Table 3: COVID-19 Indicators (Number of Cases), Russia and Global, 2021
Table 4: COVID-19-Related Travel Restrictions, Russia, 2020-2021
Table 5: Available COVID-19 IVD products, Russia, 2020-2021
Table 6: Medical Devices Market, Russia, Major Segments ($B), 2020
Table 7: Hospital Supplies Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 8: General Surgery Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 9: Orthopedic Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 10: Cardiovascular Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 11: Anesthesia and Respiratory Devices Market, Russia, Revenue ($M) and Market Share (%) of Major Companies, 2020
Table 12: Medical Equipment Risk Classification, Russia, 2020
Table 13: Patent Fees, Russia, 2020
Table 14: Trade Fairs, Russia

List of Figures

Figure 1: Pharmaceutical Market, Russia, Revenue ($B and RUB B), 2015-2020
Figure 2: Medical Device Market, Russia, Revenue ($B), 2016-2021
Figure 3: Healthcare Start-Ups in Russia, 2020
Figure 4: Country Profile, Russia, 2020
Figure 5: Pharmaceutical Market, Russia, Revenue ($B and RUB B), 2015-2020
Figure 6: Pharmaceutical Market, Russia, Revenue Forecast ($B and RUB B), 2021-2026
Figure 7: Pharmaceutical Exports ($B), Russia, 2011-2020
Figure 8: Top Export Partners, Russia, 2020
Figure 9: Pharmaceutical Imports ($B), Russia, 2011-2020
Figure 10: Top Import Partners, Russia, 2020
Figure 11: Russian Pilot Innovative Clusters Specialized in Pharmaceuticals and Medical Device, Russia, 2019
Figure 12: OTC Market, Revenue ($B), Russia, 2011-2020
Figure 13: OTC Medicines Market, Major Distribution Channels ($M), Russia, 2020
Figure 14: OTC Medicines Market, Major Market Value Segmentation (%), Russia, 2020
Figure 15: Major Therapeutic Categories Based on Mortality by Major Disease Areas (Thousands), Russia, 2019
Figure 16: COVID-19 (Number of Cases), Russia, 2020-2021
Figure 17: COVID-19 (Number of Deaths), Russia, 2020-2021
Figure 18: COVID-19 Fiscal and Monetary Stimulus Timeline, Russia, 2020-2021
Figure 19: COVID-19 Vaccine Administration, Number of Administered Doses, Russia, 2020-2021
Figure 20: Top COVID-19 Markets by Product Categories (Number of available marketed products), Russia, 2020-2021
Figure 21: Top COVID-19 IVD Products by Device Class (Number of available marketed products), Russia, 2020-2021
Figure 22: COVID-19 Clinical Trials Sponsors by Count, Russia, 2020-2021
Figure 23: COVID-19 Clinical Trials Count by Phase, Russia, 2020-2021
Figure 24: COVID-19 Clinical Trials Count by Trial Status, Russia, 2020-2021
Figure 25: Medical Devices Market, Russia, Revenue ($B), 2016-2021
Figure 26: Medical Devices Market, Russia, Revenue Forecast ($B), 2022-2026
Figure 27: Medical Devices Market, Russia, Major Segments (%), 2020
Figure 28: Hospital Supplies Market, Russia, Revenue ($B), 2017-2025
Figure 29: Hospital Supplies Market, Russia, Market Share of Major Players (%), 2020
Figure 30: General Surgery Devices Market, Russia, Revenue ($B), 2017-2025
Figure 31: General Surgery Devices Market, Russia, Market Share of Major Players (%), 2020
Figure 32: Orthopedic Devices Market, Russia, Revenue ($B), 2017-2025
Figure 33: Orthopedic Devices Market, Russia, Market Share of Major Players (%), 2020
Figure 34: Cardiovascular Devices Market, Russia, Revenue ($B), 2017-2025
Figure 35: Cardiovascular Devices Market, Russia, Market Share of Major Players (%), 2020
Figure 36: Anesthesia and Respiratory Devices Market, Russia, Revenue ($B), 2017-2025
Figure 37: Anesthesia and Respiratory Devices Market, Russia, Market Share of Major Players (%), 2020
Figure 38: Diagnostic Market, Russia, Revenue ($B), 2016-2021
Figure 39: Diagnostic Market, Russia, Revenue ($B), 2022-2026
Figure 40: Medical Devices Market, Russia, Revenue ($M) of Major Companies, 2020
Figure 41: Deal Value and Deal Count, Pharmaceutical Market, Russia, 2020-2021
Figure 42: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Russia, 2020-2021
Figure 43: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Russia, 2020-2021
Figure 44: Top Therapy Areas by Deal Value ($M), Pharmaceutical Market, Russia, 2020-2021
Figure 45: Top Therapy Areas by Deal Count, Pharmaceutical Market, Russia, 2020-2021
Figure 46: M&A Deals by Quarter, Pharmaceutical Market, Russia, 2020-2021 (by value and by number)
Figure 47: Deal Value and Deal Count, Medical Devices Market, Russia, 2020-2021
Figure 48: Deal Value and Deal Count Subtypes, Medical Devices Market, Russia, 2020-2021
Figure 49: Deal Value and Deal Count, Quarterly, Medical Devices Market, Russia, 2020-2021
Figure 50: Top Equipment Sectors by Deal Value ($M), Medical Devices Market, Russia, 2020-2021
Figure 51: Top Equipment Sectors by Deal Count, Medical Devices Market, Russia, 2020-2021
Figure 52: M&A Deals by Quarter, Medical Devices Market, Russia, 2020-2021 (by value and by number)
Figure 53: Deal Value and Deal Count, HealthTech, Russia, 2020-2021
Figure 54: Top VC Investors by Deal Value and Deal Count, HealthTech, Russia, 2020-2021
Figure 55: Organization of Healthcare System, Russia, 2020
Figure 56: Out-Patient Drug Reimbursement Eligibility, Russia, 2019
Figure 57: Public Provision of Pharmaceuticals, Russia, 2020
Figure 58: Government Health Insurance (% of population), Russia, 2010-2018
Figure 59: Out-of-Pocket Spending ($ per Capita), Russia, 2012-2019
Figure 60: Consumer Price Index, Health (2015=100), Russia, 2016-2020
Figure 61: Drug Price Regulation, Russia, 2020
Figure 62: Filing Procedure for Registration of Maximum Selling Price for EDL Drugs, Russia, 2020
Figure 63: Roszdravnadzor, Organizational Chart, Russia, 2020
Figure 64: Rospotrebnadzor, Organizational Chart, Russia, 2020
Figure 65: Drug Approval Process, Russia, 2020
Figure 66: Drug Approval Overall Process, Russia, 2020
Figure 67: Rospatent Organization Structure, Russia, 2020
Figure 68: Patent Approval Process, Russia, 2020
Figure 69: Pharmaceutical Clinical Trials Count by Trial Status, Russia, 2020-2021
Figure 70: Pharmaceutical Clinical Trials Count by Indication, Russia, 2020-2021
Figure 71: Pharmaceutical Clinical Trials Count by Phase, Russia, 2020-2021
Figure 72: Pharmaceutical Clinical Trials Count by Sponsors, Russia, 2020-2021
Figure 73: Medical Devices Clinical Trials Count by Trial Status, Russia, 2020-2021
Figure 74: Medical Devices Clinical Trials Count by Device Category, Russia, 2020-2021
Figure 75: Medical Devices Clinical Trials Count by Indication, Russia, 2020-2021
Figure 76: Top Five Medical Devices Clinical Trials Sponsors by Count, Russia, 2020-2021
Figure 77: Labeling information, Russia, 2020
Figure 78: Health Strategy 2020, Russia, 2020
Figure 79: Number of Hospitals & Outpatient Clinics (‘000), Russia, 2013-2020
Figure 80: Number of Diagnostic Equipment Units (per 100,000 population), Russia, 2013-2020
Figure 81: Number of Hospital Beds* (per 1,000 Population), Russia, 2011-2019
Figure 82: Number of Hospital Beds by Specialization (%), Russia, 2019
Figure 83: Life Expectancy at Birth (Years), Russia, 2013-2020
Figure 84: Immunization Rate (% of Children Ages 12-23 months), Russia, 2013-2020
Figure 85: PM2.5 (µg per m3), Russia, 2012-2020
Figure 86: CO2 Emissions (Mt of CO2 ), Russia, 2012-2020
Figure 87: Physicians (per 10,000 Population), Russia, 2013-2020
Figure 88: Nurses (per 10,000 Population), Russia, 2010-2020
Figure 89: Dentists (per 1,000 Population), Russia, 2010-2020
Figure 90: Major Causes of Mortality (per 100,000 population), Russia, 2019
Figure 91: Major Causes of Male Mortality (per 100,000 population), Russia, 2019
Figure 92: Major Causes of Female Mortality (per 100,000 population), Russia, 2019
Figure 93: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Russia, 2019
Figure 94: Healthcare Expenditure as Percentage of GDP (%), Russia, 2012-2020
Figure 95: Health Expenditure Share (% of Health Spending), Russia, 2012-2019

PURCHASE OPTIONS

Single User License PDF

Site License PDF

Enterprise License PDF

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1937EUR$1,995USD£1,668GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3873EUR$3,990USD£3,335GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5810EUR$5,985USD£5,003GBP

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Russia, and includes:

Reasons to Buy

Table of Contents

Related Topics

Related Reports

Global Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Regional Outlook and Forecast, 2023-2029

Healthcare Reimbursement Global Market Report 2024

Disease Management Apps Global Market Report 2024

Europe Disease Management Apps Market Size, Share & Industry Trends Analysis Report By Indication (Obesity, Mental Health, Cardiovascular Issues, Diabetes and Others), By Device, By Platform Type, By Country and Growth Forecast, 2023-2029

Mid-Revenue Cycle Management / Clinical Documentation Improvement - Global Strategic Business Report